{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T16:00:48Z","timestamp":1768233648051,"version":"3.49.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2003,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.fertnstert.2016.09.013","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T09:47:11Z","timestamp":1477388831000},"page":"1608-1614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Steroid hormone pretreatments in assisted reproductive technology"],"prefix":"10.1016","volume":"106","author":[{"given":"Jean","family":"Nassar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teddy","family":"Tadros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Adda-Herzog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Marc","family":"Ayoubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Fanchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.09.013_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/oxfordjournals.humrep.a136736","article-title":"Cellular aspects of preovulatory folliculogenesis in primate ovaries","volume":"3","author":"Hillier","year":"1988","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib2","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":"Testosterone stimulates primate ovarian follicle growth","volume":"101","author":"Vendola","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib3","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","article-title":"Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development","volume":"84","author":"Weil","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/molehr\/gaq073","article-title":"In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA","volume":"17","author":"Nielsen","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/humrep\/deg115","article-title":"Ultrasound examination of polycystic ovaries: is it worth counting the follicles?","volume":"18","author":"Jonard","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib6","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of antimullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endoc Metab"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib7","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/oxfordjournals.humrep.a019405","article-title":"Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome","volume":"11","author":"Takayama","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib8","first-page":"15","article-title":"In\u00a0vitro production of androgens by a virilizing adrenal adenoma and associated polycystic ovaries","volume":"44","author":"Kase","year":"1963","journal-title":"Acta Endocrinologica"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-2008-1068383","article-title":"The role of the adrenal in polycystic ovarian syndrome","volume":"2","author":"Lobo","year":"1984","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/jcem-59-3-389","article-title":"The effect of continuous androgen secretion on the hypothalamic-pituitary axis in woman: evidence from a luteinized thecoma of the ovary","volume":"59","author":"Dunaif","year":"1984","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib11","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/humrep\/15.10.2129","article-title":"Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series","volume":"15","author":"Casson","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib12","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1093\/humrep\/del254","article-title":"Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF","volume":"21","author":"Barad","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1477-7827-9-67","article-title":"Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)","volume":"9","author":"Gleicher","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib14","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/humrep\/del052","article-title":"Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH","volume":"21","author":"Balasch","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib15","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/humrep\/dei481","article-title":"Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique\u2013a prospective, randomized, double-blind study","volume":"21","author":"Massin","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/humrep\/den428","article-title":"Transdermal testosterone may improve ovarian response to gonadotropins in low-responder IVF patients: a randomized, clinical trial","volume":"24","author":"F\u00e1bregues","year":"2009","journal-title":"Human Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib17","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/humrep\/dep442","article-title":"Effects of exogenous testosterone supplementation in gonadotropin stimulated cycles","volume":"25","author":"Sipe","year":"2010","journal-title":"Human Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/humrep\/dem388","article-title":"Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation","volume":"23","author":"Durnerin","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10815-009-9322-x","article-title":"Human choriogonadotropin prior to controlled ovarian stimulation and in\u00a0vitro fertilization improves implantation, and pregnancy rates","volume":"26","author":"Motta","year":"2009","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1477-7827-7-91","article-title":"\u201chCG priming\u201d effect in controlled ovarian stimulation through a long protocol","volume":"7","author":"Beretsos","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib21","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/humrep\/deg311","article-title":"Aromatase inhibition reduces gonadotropin dose required for controlled ovarian stimulation in women with unexplained infertility","volume":"18","author":"Mitwally","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.fertnstert.2005.01.117","article-title":"The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in\u00a0vitro fertilization outcome in low responder patients: a pilot study","volume":"84","author":"Garcia-Velasco","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib23","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/jc.2005-1923","article-title":"Review: aromatase inhibitors for ovulation induction","volume":"91","author":"Casper","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.fertnstert.2007.02.013","article-title":"Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist\/letrozole protocol?","volume":"89","author":"Schoolcraft","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1210\/me.2010-0006","article-title":"Granulosa cell\u2013specific androgen receptors are critical regulators of ovarian development and function","volume":"24","author":"Sen","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1095\/biolreprod.112.102012","article-title":"Targeted loss of androgen receptor signaling in murine granulosa cells of preantral and antral follicles causes female subfertility","volume":"87","author":"Walters","year":"2012","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3109\/09513590.2013.824957","article-title":"A prospective study on role of dehydroepiandrosterone (DHEA) on improving the ovarian reserve markers in infertile patients with poor ovarian reserve","volume":"29","author":"Singh","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1210\/jc.2012-3071","article-title":"A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency","volume":"98","author":"Yeung","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejogrb.2012.12.017","article-title":"DHEA supplementation may improve IVF outcome in poor responders: a proposed mechanism","volume":"168","author":"Hyman","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib30","doi-asserted-by":"crossref","first-page":"E717","DOI":"10.1152\/ajpendo.00263.2013","article-title":"Characterizing the neuroendocrine and ovarian defects of androgen receptor\u2013knockout female mice","volume":"305","author":"Cheng","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1423-0127-20-93","article-title":"Reduced quality and accelerated follicle loss with female reproductive aging\u2014does decline in theca dehydroepiandrosterone (DHEA) underlie the problem?","volume":"20","author":"Ford","year":"2013","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13048-014-0093-3","article-title":"Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in\u00a0vitro fertilization: a randomized controlled trial","volume":"7","author":"Zhang","year":"2014","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.tjog.2014.09.003","article-title":"Gene expression of cumulus cells in women with poor ovarian response after dehydroepiandrosterone supplementation","volume":"53","author":"Tsui","year":"2014","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.fertnstert.2014.03.044","article-title":"A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in\u00a0vitro fertilization outcomes in poor responders","volume":"102","author":"Yeung","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.12891\/ceog16742014","article-title":"DHEA pre-treated patients, poor responders to a first IVF (ICSI) cycle: clinical results","volume":"41","author":"Poli","year":"2014","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2013.11.008","article-title":"Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?","volume":"173","author":"Kara","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tjog.2014.07.007","article-title":"Effects of dehydroepiandrosterone supplementation on women with poor ovarian response: a preliminary report and review","volume":"54","author":"Tsui","year":"2015","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.rbmo.2014.10.005","article-title":"Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study","volume":"30","author":"Vlahos","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0974-1208.165142","article-title":"Dehydroepiandrosterone as an adjunct to gonadotropins in infertile Indian women with premature ovarian aging: a pilot study","volume":"8","author":"Malik","year":"2015","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejogrb.2016.02.009","article-title":"Does dehydroepiandrosterone improve pregnancy rate in women undergoing IVF\/ICSI with expected poor ovarian response according to the Bologna criteria? A randomized controlled trial","volume":"200","author":"Kotb","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.fertnstert.2010.07.1077","article-title":"The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders","volume":"95","author":"Kim","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.12717\/DR.2014.18.3.145","article-title":"Ovarian features after 2 weeks, 3 weeks and 4 weeks transdermal testosterone gel treatment and their associated effect on IVF outcomes in poor responders","volume":"18","author":"Kim","year":"2014","journal-title":"Dev Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3892\/etm.2014.1683","article-title":"Effect of pretreatment with transdermal testosterone on poor ovarian responders undergoing IVF\/ICSI: A meta-analysis","volume":"8","author":"Luo","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib44","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/humrep\/dew028","article-title":"Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial","volume":"31","author":"Bosdou","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib45","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0015-0282(16)60853-1","article-title":"Short-term luteinizing hormone-releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in\u00a0vitro fertilization","volume":"52","author":"Macnamee","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib46","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0015-0282(16)55806-3","article-title":"Comparison of short 7-day and prolonged treatment with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation","volume":"59","author":"Hazout","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib47","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(16)56933-7","article-title":"The single or dual administration of the gonadotropin-releasing hormone antagonist cetrorelix in an in\u00a0vitro fertilization\u2013embryo transfer program","volume":"62","author":"Olivennes","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib48","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/oxfordjournals.humrep.a138597","article-title":"Suppression of the endogenous luteinizing hormone surge by the gonadotropin-releasing hormone antagonist cetrorelix during ovarian stimulation","volume":"9","author":"Diedrich","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib49","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1023\/A:1020381310860","article-title":"Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues","volume":"15","author":"Biljan","year":"1998","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib50","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0015-0282(16)54963-2","article-title":"The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in\u00a0vitro fertilization","volume":"57","author":"Tan","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib51","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception","author":"Al-Inany","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib52","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0015-0282(02)04574-0","article-title":"Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens","volume":"79","author":"Fanchin","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib53","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/deg516","article-title":"Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib54","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1210\/jcem-56-5-1022","article-title":"Follicular development during the luteal phase\u00a0of the human menstrual cycle","volume":"56","author":"McNatty","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib55","first-page":"71","article-title":"Manipulation of human ovarian function: physiological concepts and clinical consequences","volume":"18","author":"Fauser","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib56","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1530\/jrf.0.0690497","article-title":"Evolution of the diameters of the largest healthy and atretic follicles during the human menstrual cycle","volume":"69","author":"Gougeon","year":"1983","journal-title":"J Reprod Fertil"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/edrv-17-2-121","article-title":"Regulation of ovarian follicular development in primates: facts and hypotheses","volume":"17","author":"Gougeon","year":"1996","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib58","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1210\/jcem-50-4-640","article-title":"Intraovarian sex steroid hormone interactions and the regulation of follicular maturation: aromatization of androgens by human granulose cells in\u00a0vitro","volume":"50","author":"Hillier","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib59","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/jcem-64-6-1109","article-title":"Hormonal dynamics during luteal-follicular transition","volume":"64","author":"Mais","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib60","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1210\/jcem-69-5-1033","article-title":"Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle","volume":"69","author":"Roseff","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib61","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1210\/endo.137.4.8625923","article-title":"Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor","volume":"137","author":"Chun","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib62","first-page":"1038","article-title":"Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women","volume":"81","author":"Klein","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib63","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1093\/humrep\/14.12.3002","article-title":"Selection of good embryos for transfer depends on embryo cohort size: implications for the \u201cmild ovarian stimulation\u201d debate","volume":"14","author":"Devreker","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0015-0282(16)36901-1","article-title":"Elucidation of normal ovarian physiology by exogenous gonadotropin stimulation following steroid pituitary suppression","volume":"20","author":"Jones","year":"1969","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib65","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1471-0528.1971.tb00266.x","article-title":"The ovarian response to gonadotropins after administration of an oral contraceptive","volume":"78","author":"Pujol-Amat","year":"1971","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib66","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0015-0282(16)49644-5","article-title":"A new approach to follicular stimulation for in\u00a0vitro fertilization: programed oocyte retrieval","volume":"46","author":"Frydman","year":"1986","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib67","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0015-0282(16)59845-8","article-title":"The use of oral contraceptives to regulate oocyte retrieval","volume":"49","author":"Patton","year":"1988","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1749-6632.1988.tb22240.x","article-title":"Protocols for induction of ovulation. The concept of programmed cycles","volume":"541","author":"Mashiach","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib69","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/oxfordjournals.humrep.a135990","article-title":"Semi-programmed ovarian stimulation as the first choice in in-vitro fertilization programmes","volume":"10","author":"Franco J\u00fanior","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib70","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in\u00a0vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib71","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/BF02066431","article-title":"Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation","volume":"13","author":"Lindheim","year":"1996","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib72","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0015-0282(97)81862-6","article-title":"Improved controlled ovarian hyperstimulation in poor responder in\u00a0vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol","volume":"67","author":"Schoolcraft","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib73","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0015-0282(98)00333-1","article-title":"Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates","volume":"70","author":"Biljan","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib74","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0015-0282(99)00423-9","article-title":"Microdose follicular phase gonadotropin-releasing hormone agonist (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in\u00a0vitro fertilization","volume":"72","author":"Leondires","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib75","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0015-0282(99)00584-1","article-title":"Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression","volume":"73","author":"Branigan","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib76","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1472-6483(10)60621-9","article-title":"Effect of an oral contraceptive pill on follicular development in IVF\/ICSI patients receiving a GnRH antagonist: a randomized study","volume":"13","author":"Huirne","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib77","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humrep\/dei302","article-title":"Orgalutran Scheduling Study Group. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist\u2013treated patients","volume":"2","author":"Rombauts","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib78","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/humrep\/dei348","article-title":"Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial","volume":"21","author":"Kolibianakis","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/humrep\/del340","article-title":"Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol","volume":"22","author":"C\u00e9drin-Durnerin","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib80","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.fertnstert.2009.05.013","article-title":"Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF\/intracytoplasmic sperm injection","volume":"92","author":"Kim","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib81","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5653\/cerm.2011.38.4.228","article-title":"GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF\/ICSI","volume":"38","author":"Kim","year":"2011","journal-title":"Clin Exp Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib82","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.fertnstert.2007.05.025","article-title":"A luteal estradiol protocol for expected poor-responders improves embryo number and quality","volume":"89","author":"Frattarelli","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib83","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.fertnstert.2012.02.028","article-title":"Groupe d\u2019Etude en M\u00e9decine et Endocrinologie de la Reproduction. Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized trial","volume":"97","author":"C\u00e9drin-Durnerin","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib84","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.fertnstert.2005.04.031","article-title":"Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in\u00a0vitro fertilization in poor responders","volume":"84","author":"Dragisic","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib85","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10815-011-9685-7","article-title":"Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization","volume":"29","author":"Chang","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib86","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.fertnstert.2007.12.073","article-title":"A luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates","volume":"91","author":"Hill","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib87","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.fertnstert.2008.04.024","volume":"92","author":"Weitzman","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib88","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.fertnstert.2010.10.003","article-title":"Stimulation of the young poor responder: comparison of the luteal estradiol\/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide","volume":"95","author":"Shastri","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib89","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3109\/09513590.2011.569596","volume":"27","author":"Ata","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib90","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1477-7827-11-96","article-title":"Cycle scheduling for in\u00a0vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial","volume":"11","author":"Hauzman","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib91","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1055\/s-2005-923393","article-title":"Coordination of antral follicle growth: basis for innovative concepts of controlled ovarian hyperstimulation","volume":"23","author":"Fanchin","year":"2005","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib92","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0015-0282(00)01702-7","article-title":"Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women","volume":"75","author":"Erb","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib93","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/09513590.2012.736558","article-title":"Effects of luteal estradiol pre-treatment on the outcome of IVF in poor ovarian responders","volume":"3","author":"Chang","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.09.013_bib94","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/humrep\/det306","article-title":"Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis","volume":"28","author":"Reynolds","year":"2013","journal-title":"Hum Reprod"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216628030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216628030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T12:33:30Z","timestamp":1768221210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216628030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":94,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0015028216628030"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.09.013","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Steroid hormone pretreatments in assisted reproductive technology","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a92016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}